The 2026 Self-Nomination Toolkit for Qualified Clinical Data Registries and Qualified Registries, including the below files, are now posted on the QPP Resource Library.
Read More
The U.S. Food and Drug Administration is announcing a public meeting to discuss proposed recommendations for the reauthorization of the Medical Device User Fee Amendments (MDUFA) for fiscal years 2028 through 2032. The current legislative authority for MDUFA expires on Sept. 30, 2027.
Comment period ended on June 16 for the much talked about RFI on the Health Information Ecosystem. Here are organizations that have shared their submitted comments.
HHS Secretary Kennedy and CMS Administrator Oz press conference on securing industry pledges to fix the broken Prior Authorization System. They met with insurance leaders of nearly 80% of covered Americans.
The EHR Association shared its feedback on two NPRMs recently: to ASTP/ONC regarding the 2025 Standards Version Advancement Process (SVAP), and to CMS regarding the FY 2026 IPPS proposed rule (CMS–1833–P).
By Jackie Fortier – A document the Department of Health and Human Services sent to lawmakers to support Secretary Robert F. Kennedy Jr.’s decision to change U.S. policy on covid vaccines cites scientific studies that are unpublished or under dispute and mischaracterizes others.
CMS opened the Doctors and Clinicians Preview Period on Tuesday, May 27, 2025.The Preview Period gives clinicians and groups the ability to review their 2023 QPP performance information before it’s publicly reported on the profile pages of clinicians and groups on the Medicare.gov compare tool and in the Provider Data Catalog.
By Mary Griskewicz – CMS has reengaged with the healthcare industry and the public for comment after a period of silence, now with the Department’s reorganization well underway. In a relatively short period, CMS has put out three requests for information, new strategic guidance for its Center of Innovation, and announced rescinding previously published documentation.
By Lisa Nelson – Interoperability in healthcare has come a long way, but it has been slow going. The introduction of FHIR holds many promises, but there’s a practical challenge: how do we shift the industry to use more modern, more standardized structured health information?